# Sharp to package Alnylam RNAi therapeutics for Europe at Belgian site

Alnylam Pharmaceuticals and Sharp agreed that Sharp's Hamont-Achel site in Belgium will package all Alnylam products across European countries. Alnylam describes it as its first significant international investment in Belgium.

- Type: Contract
- Announced: 2020-09-25
- Where: Hamont-Achel, Belgium
- Status: announced
- Products: pharmaceutical packaging for RNAi therapeutics, injectables and cold-chain packaging
- Sectors: [Packaging](https://endata.com/sectors/packaging.md)

## Companies

- [Sharp](https://endata.com/companies/3595.md) (supplier)
- [Alnylam Pharmaceuticals](https://endata.com/companies/7063.md) (customer)

## Sources

- [pharmoutsourcing.com](https://www.pharmoutsourcing.com/1315-News/568560-Alnylam-Partners-with-Sharp-on-Packaging-RNAi-Therapeutics-for-Europe/), 2020-09-25: "Sharp Belgium's Hamont-Achel site will be responsible for the packaging of all Alnylam's products across European countries."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.